RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.8636
-0.0165 (-1.87%)
At close: May 8, 2026, 4:00 PM EDT
0.8808
+0.0172 (1.99%)
After-hours: May 8, 2026, 5:57 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $38.91 million as of May 8, 2026. Its market cap has increased by 8.63% in one year.
Market Cap
38.91M
Enterprise Value
32.10M
1-Year Change
8.63%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $38.91M, a decrease of -43.32%. That is a compound annual growth rate of -11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 39.65M | 28.78% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperion DeFi | 40.78M |
| Daré Bioscience | 39.46M |
| Tvardi Therapeutics | 39.40M |
| INmune Bio | 38.81M |
| Actinium Pharmaceuticals | 38.75M |
| Aligos Therapeutics | 38.30M |
| CervoMed | 37.87M |
| Mereo BioPharma Group | 37.57M |